Cohance Lifesciences Limited Tetracycline Export Data — India (DGFT 2022–2026)

Name: Cohance Lifesciences Limited Tetracycline Export Records India — #4 Exporter, 36 Shipments, $1.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tetracycline

India Pharmaceutical Trade Intelligence

$16.9M263 Suppliers128 CountriesHS 30042049

ExportsIndia → TANZANIA15.9%India → UNITED STATES11.3%

ImportsCHINA → India$225.7M UNITED KINGDOM → India$506.7K

Cohance Lifesciences Limited — Tetracycline Exporter #4 | $1.5M Trade Value | TransData Nexus | TransData Nexus

Cohance Lifesciences Limited — Tetracycline Exporter Profile

Indian Pharmaceutical Exporter · #4 for Tetracycline · $1.5M export value · DGFT Verified

Cohance Lifesciences Limited is the #4 Indian exporter of Tetracycline with $1.5M in export value and 36 verified shipments. Cohance Lifesciences Limited holds a 8.6% market share in Tetracycline exports across 1 countries. The company exports 4 pharmaceutical products worth $13.6M across 4 therapeutic categories.

Cohance Lifesciences Limited — Tetracycline Export Profile: Buyers & Destinations

Cohance Lifesciences Limited Tetracycline export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Tetracycline?

Country	Value	Shipments	Share
UNITED STATES	$1.9M	92	16.8%
TANZANIA	$1.9M	37	16.3%
CONGO DR	$1.5M	61	13.3%
ETHIOPIA	$1.5M	67

Who Are the Top Buyers of Tetracycline from India?

Buyer	Country	Value	Orders
STE PRINCE PHARMA SARL	CONGO DR	$1.8M	72
CARDINAL HEALTH	UNITED STATES	$1.5M	39
HEKO PHARMACY LTD	TANZANIA	$400.0K	8
PRINCE FARMA LDA,	ANGOLA	$251.9K	7
TROGE MEDICAL GMBH	GERMANY	$250.0K	5
IMRES B.V.	NETHERLANDS	$219.6K	12
ETHIOPIAN PHARMACEUTICALS SUPPLY	ETHIOPIA	$150.0K	3
UNICEF SUPPLY DIVISION	DENMARK	$100.0K	2
NEW CESAMEX S	CONGO	$100.0K	2
ETHIOPIAN PHARMACEUTICALS	ETHIOPIA	$100.0K	2

India's Tetracycline is purchased by 660 buyers worldwide. The top buyer is STE PRINCE PHARMA SARL (CONGO DR), followed by CARDINAL HEALTH and HEKO PHARMACY LTD.

How Does Cohance Lifesciences Limited Compare to Nearest Tetracycline Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	GALENTIC PHARMA INDIA PVT LTD	$2.3M	85	13	$27.2K
3	PRASHI PHARMA PRIVATE LIMITED	$1.5M	63	4	$23.4K
4	COHANCE LIFESCIENCES LIMITED ★	$1.5M	36	1	$40.5K
1	LINCOLN PHARMACEUTICALS LTD	$700.0K	14	2	$50.0K
5	VIDACARE MEDICA PRIVATE LIMITED	$558.4K	18	3	$31.0K

Cohance Lifesciences Limited ranks #4 among 263 Indian Tetracycline exporters. Average shipment value of $40.5K compared to the market average of $36.8K. The closest competitors by value are GALENTIC PHARMA INDIA PVT LTD and PRASHI PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Tetracycline Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	438	15.5%
SAHAR AIR CARGO ACC (INBOM4)	393	13.9%
SAHAR AIR	355	12.5%
DELHI AIR	253	8.9%
NHAVA SHEVA SEA (INNSA1)	224	7.9%
JNPT	130	4.6%
Bombay Air	121	4.3%
JNPT/ NHAVA SHEVA SEA	114	4.0%

Geopolitical & Trade Policy Impact on Cohance Lifesciences Limited's Tetracycline Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Cohance Lifesciences. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and shipping costs. This situation necessitates strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost efficiency.

Conversely, the U.S.-China trade tensions have opened avenues for Indian exporters to capture market share previously dominated by Chinese manufacturers. Cohance's established presence and compliance with international standards position it favorably to meet the increased demand from U.S. importers seeking reliable alternatives.

The recent India-European Union Free Trade Agreement (FTA), concluded on January 27, 2026, eliminates tariffs on Indian pharmaceutical exports to the EU, including duties of up to 11% on pharmaceuticals. This development enhances Cohance's competitiveness in the European market, potentially boosting export volumes and revenues. (en.wikipedia.org)

Cohance Lifesciences Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. The USFDA's issuance of a warning letter to Cohance's Hyderabad facility highlights the critical importance of adhering to Good Manufacturing Practices (GMP). While the immediate financial impact may be minimal due to the facility's limited contribution to U.S. revenues, the long-term implications on reputation and market access are significant. Proactive remediation and transparent communication with regulatory bodies are essential to restore and maintain compliance.

Additionally, the European Union's Falsified Medicines Directive (FMD) imposes stringent requirements on pharmaceutical imports. Cohance must ensure robust serialization and traceability measures to comply with these regulations, thereby safeguarding its access to the lucrative EU market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tetracycline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cohance Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 128+ countries, 660+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tetracycline

Tetracycline

Cohance Lifesciences Limited — Tetracycline Exporter Profile

Cohance Lifesciences Limited — Tetracycline Export Profile: Buyers & Destinations

Where Does India Export Tetracycline?

Who Are the Top Buyers of Tetracycline from India?

What Is India's Total Tetracycline Export Value and How Much Does Cohance Lifesciences Limited Contribute?

What Is the Average Shipment Value for Cohance Lifesciences Limited's Tetracycline Exports?

How Does Cohance Lifesciences Limited Compare to Other Indian Tetracycline Exporters?

Regulatory Requirements: Exporting Tetracycline to Key Markets

United States — FDA

How Does Cohance Lifesciences Limited Compare to Nearest Tetracycline Exporters?

Which Indian Ports Ship Tetracycline Exports?

Geopolitical & Trade Policy Impact on Cohance Lifesciences Limited's Tetracycline Exports

Cohance Lifesciences Limited — Regulatory Compliance & Quality Standards

About Cohance Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tetracycline Export Data from Cohance Lifesciences Limited

Tetracycline Stats

Company Overview

Top Products by Cohance Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source